- testing |
| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 20 May 2025 | 13 May 2025 |
| Torrent Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2025 inter alia to consider and approve the Audited Financial Results of the Company for the year ended on 31-Mar-25; Recommendation of final dividend; Taking enabling resolutions for raising of funds by issue of Equity Shares including Convertible Bonds / Debentures through QIP and / or Depository Receipts or any other modes. Outcome of Board meeting dated 20-May-25 (As Per BSE Announcement Dated on :20.05.2025) | ||
| Board Meeting | 24 Jan 2025 | 13 Jan 2025 |
| TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-24. The Board would also consider payment of Interim Dividend for the year 2024-25. Outcome of Board Meeting Dated 24-Jan-25. Dividend Updates (As per BSE Announcement Dated on 24/01/2025) | ||
| Board Meeting | 25 Oct 2024 | 10 Oct 2024 |
| TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-24. Results Q2 FY 2024-25. (As Per BSE Announcement dated on 25.10.2024) | ||
| Board Meeting | 23 Jul 2024 | 5 Jul 2024 |
| TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2024 inter alia to consider and approve We would like to inform you that a meeting of the Board of Directors will be held on Tuesday 23-Jul-24 inter alia to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter ended on 30-Jun-24. Outcome of Board Meeting Dated 23-07-2024. (As Per BSE Announcement dated on 23.07.2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.